by Michael W. Dorsey, Worcester Polytechnic Institute Researchers at Worcester Polytechnic Institute (WPI) have developed a chip made of carbon nanotubes that can capture circulating tumor cells (CTCs) of all sizes and types, and can do so with far greater sensitivity than existing technologies. The unique design of the device makes it possible to easily...
Tag: <span>Breast Cancer</span>
Post
Living with advanced breast cancer
Sponsored Content by Eisai This article is intended for Healthcare Professionals Breast Cancer ProgramIOB Institute of Oncology An interview with Dr Javier Cortes, Head of Breast Cancer Program, IOB Institute of Oncology, Madrid and Barcelona, Spain. When does breast cancer become “advanced”? There is a certain amount of debate surrounding the exact definition of advanced breast cancer (ABC). When we talk about clinical trials, it’s not easy to...
Post
Sugary drinks linked to breast cancer in new study — experts weigh in
Juice and soda lovers might have been concerned this week to see the release of a study in the British Medical Journal which found the consumption of sugary drinks to be “positively associated with the risk of overall cancer and breast cancer.” The study, which spanned over 100,000 people in France, included both sugary sodas and 100 percent fruit juice. Mathilde Touvier, PhD, principal investigator of the study, and...
Post
Two-in-one drug combining Herceptin with chemotherapy keeps women’s breast cancers at bay
by Institute of Cancer Research Guiding chemotherapy to a tumour by attaching it to the antibody-based target drug Herceptin (trastuzumab) is effective at treating women with breast cancer who have no other treatment options, a new clinical trial shows. The two-in-one treatment kept breast cancer at bay in women with a type of the disease called HER2-positive breast cancer who had stopped responding to existing drugs. As well as being effective in women with high HER2...
Post
Is a diabetes drug the key to aggressive breast cancer?
By Ana Sandoiu Fact checked by Paula Field New research finds that the diabetes drug metformin changes stem cancer cells in a way that makes them easier to target with a new form of treatment. The findings could help treat triple-negative breast cancer, which is particularly aggressive. Triple-negative breast cancer is an aggressive form of breast cancer...
Post
Researchers identify enzyme that suppresses immune system in breast cancer
by Duke University Medical Center Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a small number of patients are even eligible to undergo treatment with immunotherapies, and most see little benefit. But in a pre-clinical study led by the Duke Cancer Institute, researchers outlined...
Post
Clinical calculator could spare breast cancer patients five years of unnecessary hormone therapy
by The Royal Marsden NHS Foundation Trust New research confirms that an algorithm, called CTS5, can accurately identify patients who are at a significantly low risk of their breast cancer returning at a later stage. In doing so it means some patients may need to take hormone therapy for five years, rather than 10, something...
Post
Scientists discover ‘switch’ that helps breast cancer spread around the body
Researchers have unveiled clues into how breast cancer cells spread around the body IMPERIAL COLLEGE LONDON The early-stage research, led by scientists from Imperial College London and The Institute of Cancer Research, London, identified a genetic ‘switch’ in breast cancer cells that boosts the production of a type of internal scaffolding. This scaffolding is a...
Post
Predicting breast cancer metastasis by cell behavior instead of genetics
by Gina Wadas, Johns Hopkins University Researchers and clinicians don’t fully understand why some cancers spread and others do not. What they do know is that when cancer does spread, it dramatically decreases survival rates. If physicians could predict the likelihood that primary tumors will metastasize, they would be able to choose the best treatment options for patients....
Post
AI can predict breast cancer risk up to 5 years before diagnosis
By Kate Bass, B.Sc. Reviewed by Kate Anderton, B.Sc. (Editor) A team of researchers at the Massachusetts Institute of Technology (MIT) have developed a deep learning model that can predict breastcancer from mammogram images up to five years before a diagnosis can be made by doctors. Breast cancer is the most common cancer in women and is responsible for around 500,000 deaths each year worldwide. There are now many effective treatments for breast cancer, but...